Cadila Healthcare is recalling 19,536 bottles of benzonatate capsules, used to treat coughs, in the US due to wet and/or leaking capsules. The recall of the 19,536 bottles has been voluntarily initiated by the company through its US based subsidiary Zydus Pharmaceuticals USA Inc. Furthermore, the recall has been initiated under Class-II, which FDA states as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences.
Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies. It is the only Indian pharma company to launch its own patented NCE - Lipaglyn, the world’s first drug to be approved for the treatment of diabetic dyslipidemia.
